Anzeige
Mehr »
Lynx Broker
Login
Freitag, 18.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien
Magisch! Weg frei für die >Milliarden-Chance< im Pennystockmantel!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AGYB ISIN: US04280A1007 Ticker-Symbol: HDP1 
Tradegate
18.10.19
21:32 Uhr
32,435 Euro
-0,470
-1,43 %
1-Jahres-Chart
ARROWHEAD PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ARROWHEAD PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
31,500
32,400
22:53
32,030
32,360
22:00

Aktuelle News zur ARROWHEAD PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.10.Medical stocks on the move: AbbVie, Arrowhead Pharmaceuticals and Zynex42
ARROWHEAD PHARMACEUTICALS Aktien ab 5,00 US-Dollar handeln - Ohne versteckte Kosten!
16.09.Arrowhead presents initial top-line clinical data and preclinical data on RNAi candidates ARO-APOC3 and ARO-ANG317
09.09.Here's Why Arrowhead Pharmaceuticals Rose 17.6% in August30
28.08.Is Arrowhead Pharmaceuticals Inc (ARWR)'s Recently Published U.S. Patent Application A Blockbuster?14
28.08.Arrowhead earns $25M from Janssen on launch of ARO-HBV study9
21.08.Arrowhead Pharmaceuticals: Buy at the High?17
19.08.Arrowhead up 8% on optimism with high cholesterol candidate ARO-ANG317
15.08.BioBoyScout's Online Biotech Valuation Calculators Help Small Investors See Value in Arrowhead Pharmaceuticals (ARWR)11
09.08.Arrowhead Pharmaceuticals: Highlights Of A Terrific Earnings Call10
08.08.Dosing underway in Phase 2/3 study of Arrowhead's ARO-AAT in rare liver disorder2
06.08.What You'll Want to Know About Arrowhead Pharmaceuticals' Q3 Update10
06.08.Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q3 2019 Results - Earnings Call Transcript4
05.08.ARROWHEAD PHARMACEUTICALS, INC. - 10-Q, Quaterly Report1
05.08.ARROWHEAD PHARMACEUTICALS, INC. - 8-K, Current Report-
02.08.Arrowhead Pharmaceuticals - Janssen Collaboration Could Be A Game Changer8
31.07.Why Arrowhead's Promising Gene Silencing Technology Makes The Stock A Strong Buy6
19.07.Arrowhead Pharmaceuticals RNA Therapy Pipeline Is Promising11
16.07.Arrowhead's ARO-ANG3 an Orphan Drug in U.S. for HoFH; shares up 1% after hours2
27.06.Arrowhead Looks To Get Rare Liver Disease Drug Approved With Use Of Accelerated Approval17
27.06.Arrowhead's ARO-AAT Fast Track'd for liver disease8
Seite:  Weiter >>
38 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,8,1